Clinical Trials
7
Active:0
Completed:5
Trial Phases
3 Phases
Phase 2:3
Phase 3:1
Not Applicable:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (6 trials with phase data)• Click on a phase to view related trials
Phase 2
3 (50.0%)Not Applicable
2 (33.3%)Phase 3
1 (16.7%)Performance and Safety of Routine Cataract Surgery With Visiol
Completed
- Conditions
- Following Cataract Surgery
- First Posted Date
- 2021-04-30
- Last Posted Date
- 2023-11-22
- Lead Sponsor
- TRB Chemedica
- Target Recruit Count
- 100
- Registration Number
- NCT04866706
- Locations
- 🇹🇭
Rajavithi Hospital, Bangkok, Thailand
Evaluation of the Structural Modification Effect of Diacerein (Artrodar®) in Knee Osteoarthritic Patients
Phase 3
Recruiting
- Conditions
- Knee Osteoarthritis
- Interventions
- Drug: ArtrodarDrug: Placebos
- First Posted Date
- 2020-03-23
- Last Posted Date
- 2024-11-22
- Lead Sponsor
- TRB Chemedica
- Target Recruit Count
- 128
- Registration Number
- NCT04318041
- Locations
- 🇹🇭
Siriraj Hospital, Bangkoknoi, Bangkok, Thailand
REMOGEN® Omega Versus Cationorm® in the Treatment of Patients Suffering From Dry Eye
Not Applicable
Terminated
- Conditions
- Dry Eye
- First Posted Date
- 2018-03-09
- Last Posted Date
- 2020-04-20
- Lead Sponsor
- TRB Chemedica
- Target Recruit Count
- 26
- Registration Number
- NCT03460548
- Locations
- 🇫🇷
Quinze-Vingts Hospital, Paris, France
Efficacy of OSTENIL PLUS (Hyaluronic Acid) Versus SYNVISC-ONE in Patients With Tibiofemoral Osteoarthritis
Not Applicable
Completed
- Conditions
- Knee Osteoarthritis
- First Posted Date
- 2017-06-29
- Last Posted Date
- 2017-10-11
- Lead Sponsor
- TRB Chemedica
- Target Recruit Count
- 290
- Registration Number
- NCT03203408
Study of Evaluating the Duration of Efficacy of One Intra Articular Injection of Sodium Hyaluronate 2.0% in Patients With Painful Osteoarthritis of the Knee
Phase 2
Completed
- Conditions
- Osteoarthritis Patient
- Interventions
- Drug: Ostenil plus
- First Posted Date
- 2011-02-02
- Last Posted Date
- 2012-11-21
- Lead Sponsor
- TRB Chemedica
- Target Recruit Count
- 20
- Registration Number
- NCT01288001
- Locations
- 🇹🇭
Siriraj Hospital, Bangkoknoi, Bangkok, Thailand
- Prev
- 1
- 2
- Next
News
No news found